About this trial
this clinical trial is evaluating the outcome of laser assisted pulpotomy compared to conventional pulpotomy in mature teeth with symptomatic irreversible pulpitis (SIP) assessed by CBCT followed by automated segmentation using Artificial intelligence (AI).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Permanent molar teeth with symptomatic irreversible pulpitis.
The patient should be ≥ 16 to 50 years old.
Teeth should give positive response to cold testing and clinical diagnosis of SIP with or without periapical rarefaction.
Teeth will be selected only if they are restorable.
Disqualifiers
Teeth with necrotic pulp, resorption or subgingival caries.
Teeth with open apices.
Medically compromised patients.
Pregnant patients.
Trial design
Parallel
Treatments tested in this trial
Diode laser
Devicea contact-type laser, it selectively and precisely affects only the tissues directly beneath it, thereby preserving the surrounding radicular tissue
Sodium Hypochlorite Solution
Other interventionA disinfecting agent used in conventional pulpotomy procedures
Treatment groups
Trial outcomes
Primary outcomes
Assessment of healing progress
evaluating clinically the signs and symptoms of pain and it will be recorded as yes and no question. \-
Radiographic assessment of the dentin bridge formation
evaluating the dentin bridge formation using periapical radiographs and CBCT
Automated segmentation of the radicular pulp space
this will be done using CBCT imaging
Sponsors and contacts
Click on the lead sponsor to view all of their trials.